Selective Induction of Apoptosis in Melanoma Cells by Tyrosinase Promoter-Controlled CD95 Ligand Overexpression
- 1 January 2005
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 124 (1) , 221-228
- https://doi.org/10.1111/j.0022-202x.2004.23572.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplantsOncogene, 2003
- A novel tetracycline-controlled transactivator–transrepressor system enables external control of oncolytic adenovirus replicationGene Therapy, 2003
- Death Receptor Signaling in Cancer TherapyCurrent Medicinal Chemistry - Anti-Cancer Agents, 2003
- The kiss of death: promises and failures of death receptors and ligands in cancer therapyLeukemia, 2001
- Epidemiology of Cutaneous Melanoma in Germany and WorldwideSkin Pharmacology and Physiology, 2001
- Replication-selective adenoviruses as oncolytic agentsJournal of Clinical Investigation, 2000
- Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriersGene Therapy, 1999
- Establishment and Characterization of a Human Primitive Neuroectodermal Tumor Cell Line from the Cerebral HemisphereJournal of Neuropathology and Experimental Neurology, 1992
- Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.Proceedings of the National Academy of Sciences, 1976
- In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2JNCI Journal of the National Cancer Institute, 1973